Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.9 USD 0.85%
Market Cap: 339.2m USD
Have any thoughts about
Kamada Ltd?
Write Note

Kamada Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kamada Ltd
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Net Income
$15.7m
CAGR 3-Years
53%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Net Income
-$7m
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Net Income
-$115.4m
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Net Income
-$9.2m
CAGR 3-Years
22%
CAGR 5-Years
2%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Net Income
-â‚Ş29.2m
CAGR 3-Years
26%
CAGR 5-Years
-5%
CAGR 10-Years
-9%
Pluri Inc
NASDAQ:PLUR
Net Income
-$22.3m
CAGR 3-Years
25%
CAGR 5-Years
8%
CAGR 10-Years
2%
No Stocks Found

Kamada Ltd
Glance View

Market Cap
339.1m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.83 USD
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Kamada Ltd's Net Income?
Net Income
15.7m USD

Based on the financial report for Sep 30, 2024, Kamada Ltd's Net Income amounts to 15.7m USD.

What is Kamada Ltd's Net Income growth rate?
Net Income CAGR 5Y
-15%

Over the last year, the Net Income growth was 154%. The average annual Net Income growth rates for Kamada Ltd have been 53% over the past three years , -15% over the past five years .

Back to Top